The New York Genome Center has awarded grants for six projects that address the role of ethnicity in several major cancer types.
The center, based in New York City, gave out the grants through Polyethnic-1000, its research initiative that was launched in 2018 to mitigate cancer care inequities in underserved populations.
The new research projects awarded funding include a study examining how ethnic diversity affects the clinical outcomes of bladder cancer and one that will investigate the genetic and non-genetic factors that can improve understanding of colorectal cancer in Black patient populations.
The researchers undertaking these projects will work with academic health centers and community hospitals throughout the New York City region to recruit patients and conduct the studies.
More articles on oncology:
There are 568 genes that can trigger cancer, researchers say
7 things to know about oncologists’ personal finances
No. 1 for cancer care: What’s missing from rankings for this specialty?
© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.